Stocks
GlaxoSmithKline (GSK) ROE US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| ROE, % | ? | 46.4% | 141.1% | 46.4% | 36.9% | 36.9% | 15.0% | ||
| Changes by years, y/y, % | +17pp | +95pp | -95pp | -10pp | 0pp | -15.0% | |||
GlaxoSmithKline. ROE, %
GlaxoSmithKline. ROE, changes, pp
GlaxoSmithKline (GSK) ROE US GAAP (quarter values) |
||||||||
| 2024Q2 | 2024Q1 | 2024Q3 | 2024Q2 | 2024Q3 | LTM ? | |||
| ROE, % | ? | 31.2% | 32.4% | 28.8% | 28.1% | 17.9% | 15.0% | |
| Changes by years, y/y, % | -11pp | -6pp | -17pp | -14pp | -28pp | |||
| Changes by quarters, q/q, % | -6pp | +1pp | -4pp | -1pp | -10pp | |||
